Tadataka Yamada (Photographer: Kiyoshi Ota/Bloomberg via Getty Images)

Sci­ence pi­o­neer, phar­ma re­search chief, glob­al health ad­vo­cate and biotech en­tre­pre­neur Tadata­ka ‘Tachi’ Ya­ma­da has died

Tadata­ka Ya­ma­da, a tow­er­ing physi­cian-sci­en­tist who made his name in acad­e­mia be­fore trans­form­ing drug de­vel­op­ment at Glax­o­SmithK­line and de­vel­op­ing vac­cines for malar­ia and menin­gi­tis at the Gates Foun­da­tion, died un­ex­pect­ed­ly of nat­ur­al caus­es at his home in Seat­tle Wednes­day morn­ing.

He was 76. Fra­zier Health­care Part­ners’ David Socks con­firmed his death.

Known wide­ly by the mononym “Tachi,” Ya­ma­da had a glo­be­trot­ting ca­reer and ar­rived in in­dus­try rel­a­tive­ly late in life. A 2004 In­de­pen­dent ar­ti­cle not­ed GSK had asked Ya­ma­da to stay on be­yond his ap­proach­ing 60th birth­day, the com­pa­ny’s usu­al re­tire­ment age. Ya­ma­da would con­tin­ue work­ing for the next 17 years, steer­ing the Gates Foun­da­tion’s glob­al health di­vi­sion for 6 years, fund­ing Jim Wil­son’s gene ther­a­py work when few would touch it, launch­ing Take­da Vac­cines and co-found­ing a se­ries of high-pro­file biotechs.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.